Follow
Davinder Gill
Davinder Gill
Nucalix
Verified email at nucalix.com
Title
Cited by
Cited by
Year
IL-22 is required for Th17 cell–mediated pathology in a mouse model of psoriasis-like skin inflammation
HL Ma, S Liang, J Li, L Napierata, T Brown, S Benoit, M Senices, D Gill, ...
The Journal of clinical investigation 118 (2), 597-607, 2008
7532008
Review on EGFR inhibitors: critical updates
D Singh, BK Attri, RK Gill, J Bariwal
Mini reviews in medicinal chemistry 16 (14), 1134-1166, 2016
1942016
Immunotherapy reduces vascular amyloid-β in PDAPP mice
S Schroeter, K Khan, R Barbour, MT Doan, M Chen, T Guido, D Gill, ...
Journal of Neuroscience 28 (27), 6787-6793, 2008
1512008
Biopharmaceutical drug discovery using novel protein scaffolds
DS Gill, NK Damle
Current opinion in biotechnology 17 (6), 653-658, 2006
1462006
Affinity maturation of a humanized rat antibody for anti-RAGE therapy: comprehensive mutagenesis reveals a high level of mutational plasticity both inside and outside the …
WJ Finlay, O Cunningham, MA Lambert, A Darmanin-Sheehan, X Liu, ...
Journal of molecular biology 388 (3), 541-558, 2009
1132009
Amyloid-beta immunotherapy for the prevention and treatment of Alzheimer disease: lessons from mice, monkeys, and humans
CA Lemere, M Maier, L Jiang, Y Peng, TJ Seabrook
Rejuvenation research 9 (1), 77-84, 2006
1132006
Isothermal titration calorimetric study of the association of hen egg lysozyme and the anti-lysozyme antibody HyHEL-5
KA Hibbits, DS Gill, RC Willson
Biochemistry 33 (12), 3584-3590, 1994
1131994
Fundamental characteristics of the immunoglobulin VH repertoire of chickens in comparison with those of humans, mice, and camelids
L Wu, K Oficjalska, M Lambert, BJ Fennell, A Darmanin-Sheehan, ...
The Journal of immunology 188 (1), 322-333, 2012
1062012
Atypical antigen recognition mode of a shark immunoglobulin new antigen receptor (IgNAR) variable domain characterized by humanization and structural analysis
OV Kovalenko, A Olland, N Piché-Nicholas, A Godbole, D King, ...
Journal of Biological Chemistry 288 (24), 17408-17419, 2013
1042013
Improving the pharmacokinetic properties of biologics by fusion to an anti-HSA shark VNAR domain
MR Müller, K Saunders, C Grace, M Jin, N Piche-Nicholas, J Steven, ...
MAbs 4 (6), 673-685, 2012
1042012
Protein adsorption kinetics drastically altered by repositioning a single charge
JJ Ramsden, DJ Roush, DS Gill, R Kurrat, RC Willson
Journal of the American Chemical Society 117 (33), 8511-8516, 1995
971995
Coupling of aggregation and immunogenicity in biotherapeutics: T-and B-cell immune epitopes may contain aggregation-prone regions
S Kumar, SK Singh, X Wang, B Rup, D Gill
Pharmaceutical research 28, 949-961, 2011
902011
IL-13 binding agents
L Tchistiakova, MT Kasaian, DD Donaldson, XY Tan, D Gill, MX Jin, ...
US Patent 7,501,121, 2009
852009
Immunotherapy Regimes Dependent On APOE Status
R Black, L Ekman, I Lieberburg, M Grundman, J Callaway, KM Gregg, ...
US Patent App. 12/253,929, 2009
812009
Novel agonist monoclonal antibodies activate TrkB receptors and demonstrate potent neurotrophic activities
MD Qian, J Zhang, XY Tan, A Wood, D Gill, S Cho
Journal of Neuroscience 26 (37), 9394-9403, 2006
802006
Electrostatic potentials and electrostatic interaction energies of rat cytochrome b5 and a simulated anion-exchange adsorbent surface
DJ Roush, DS Gill, RC Willson
Biophysical journal 66 (5), 1290-1300, 1994
791994
Antibody capture of soluble Aβ does not reduce cortical Aβ amyloidosis in the PDAPP mouse
P Seubert, R Barbour, K Khan, R Motter, P Tang, D Kholodenko, K Kling, ...
Neurodegenerative Diseases 5 (2), 65-71, 2008
772008
Children’s experiences of epilepsy: a systematic review of qualitative studies
L Chong, NJ Jamieson, D Gill, D Singh-Grewal, JC Craig, A Ju, ...
Pediatrics 138 (3), 2016
742016
High‐throughput measurement, correlation analysis, and machine‐learning predictions for pH and thermal stabilities of Pfizer‐generated antibodies
AC King, M Woods, W Liu, Z Lu, D Gill, MRH Krebs
Protein Science 20 (9), 1546-1557, 2011
712011
Shark novel antigen receptors—the next generation of biologic therapeutics?
C Barelle, DS Gill, K Charlton
Pharmaceutical Biotechnology, 49-62, 2009
692009
The system can't perform the operation now. Try again later.
Articles 1–20